Experimental HIV vaccine generates broadly neutralising antibodies in primates

Researchers have developed an experimental HIV vaccine that successfully generated broadly neutralizing antibodies in non-human primates. By using a germline-targeting approach to guide B-cell development, the team aims to overcome the virus's ability to mutate and evade the immune system.